Becton Dickinson (BDX) EBT Margin (2009 - 2026)
Becton Dickinson's (BDX) quarterly EBT Margin came in at 11.12% in Q2 2026, down 92.0% year-over-year from 138.97% in Q2 2025, and up 1243.83% quarter-over-quarter from 0.83% in Q1 2026.
Analysis
Becton Dickinson (BDX) EBT Margin (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported EBT Margin for 18 consecutive years, with 11.12% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBT Margin fell 92.0% year-over-year to 11.12% in Q2 2026; TTM through Jun 2026 was 8.43%, a 41.0% increase from a year earlier, with the FY2025 full-year figure at 8.61%, down 132.0% from the prior year.
- EBT Margin was 11.12% for Q2 2026 at Becton Dickinson, up from 0.83% in the prior quarter.
- Over five years, EBT Margin peaked at 12.55% in Q1 2024 and troughed at 0.83% in Q1 2026.
- A 5-year average of 8.5% and a median of 9.38% in 2022 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin soared 590 bps in 2024 and plunged 806 bps in 2025, its largest moves.
- Over 5 years, EBT Margin stood at 10.49% in 2022, then fell by 27 bps to 7.63% in 2023, then retreated by 22 bps to 5.92% in 2024, then grew by 26 bps to 7.48% in 2025, then soared by 49 bps to 11.12% in 2026.
- The last three EBT Margin figures came in at 11.12% (Q2 2026), 0.83% (Q1 2026), and 7.48% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.53 Bn | 47.67 Bn | 2.32 Bn | 11.12% |
| 2 | Medline | 28.35 Bn | 25.68 Bn | 2.22 Bn | 3.06% |
| 3 | West Pharmaceutical Services | 23.58 Bn | 23.15 Bn | 329.20 Mn | 20.65% |
| 4 | Baxter International | 12.50 Bn | 10.35 Bn | 1.03 Bn | 5.34% |
| 5 | Stevanato Group S.p.A | 5.62 Bn | 5.51 Bn | 100.91 Mn | 12.62% |
| 6 | Acme United | 233.86 Mn | 228.82 Mn | 26.69 Mn | 10.05% |
| 7 | Rockwell Medical | 29.73 Mn | 4.93 Mn | 3.24 Mn | -7.32% |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 39.34% |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.42 Mn | 4.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.12% |
| Mar 31, 2026 | 0.83% |
| Dec 31, 2025 | 7.48% |
| Sep 30, 2025 | 11.75% |
| Jun 30, 2025 | 12.04% |
| Mar 31, 2025 | 4.49% |
| Dec 31, 2024 | 5.92% |
| Sep 30, 2024 | 9.45% |
| Jun 30, 2024 | 10.02% |
| Mar 31, 2024 | 12.55% |
| Dec 31, 2023 | 7.63% |
| Sep 30, 2023 | 3.56% |
| Jun 30, 2023 | 9.66% |
| Mar 31, 2023 | 10.97% |
| Dec 31, 2022 | 10.49% |
| Sep 30, 2022 | 6.72% |
| Jun 30, 2022 | 9.07% |
| Mar 31, 2022 | 9.31% |
| Dec 31, 2021 | 12.72% |
| Sep 30, 2021 | 3.11% |